BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND HER1, YOR227W
26 results:

  • 1. Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.
    Lee MX; Wong ALA; Ow S; Sundar R; Tan DSP; Soo RA; Chee CE; Lim JSJ; Yong WP; Lim SE; Goh BC; Wang L; Lee SC
    Target Oncol; 2022 Mar; 17(2):141-151. PubMed ID: 35195837
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
    Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
    Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Lapatinib.
    Voigtlaender M; Schneider-Merck T; Trepel M
    Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The prospect of patritumab for treating non-small cell lung cancer.
    Horinouchi H
    Expert Opin Biol Ther; 2016 Dec; 16(12):1549-1555. PubMed ID: 27744717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Research status quo and progression in targeted therapy for advanced gastric cancer].
    Feng R; Zhang X; Yang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1191-1196. PubMed ID: 27781258
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HER Family Protein Expression in a Greek Population with gastric cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
    Makatsoris T; Tsamandas AC; Strimpakos A; Alexopoulou Z; Dionysopoulos D; Pervana S; Konstantara A; Papakostas P; Samantas E; Rallis G; Dimou A; Pentheroudakis G; Papaparaskeva K; Psyrri A; Kalogeras KT; Syrigos K; Scopa CD; Fountzilas G
    Anticancer Res; 2016 Apr; 36(4):1581-90. PubMed ID: 27069134
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Chan A; Delaloge S; Holmes FA; Moy B; Iwata H; Harvey VJ; Robert NJ; Silovski T; Gokmen E; von Minckwitz G; Ejlertsen B; Chia SKL; Mansi J; Barrios CH; Gnant M; Buyse M; Gore I; Smith J; Harker G; Masuda N; Petrakova K; Zotano AG; Iannotti N; Rodriguez G; Tassone P; Wong A; Bryce R; Ye Y; Yao B; Martin M;
    Lancet Oncol; 2016 Mar; 17(3):367-377. PubMed ID: 26874901
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in gastric and Esophageal Adenocarcinoma.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lapatinib.
    Nolting M; Schneider-Merck T; Trepel M
    Recent Results Cancer Res; 2014; 201():125-43. PubMed ID: 24756789
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model?
    Terragni R; Casadei Gardini A; Sabattini S; Bettini G; Amadori D; Talamonti C; Vignoli M; Capelli L; Saunders JH; Ricci M; Ulivi P
    PLoS One; 2014; 9(1):e85388. PubMed ID: 24454858
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of her1 amplification with poor prognosis in well differentiated gastric carcinomas.
    Kandel C; Leclair F; Bou-Hanna C; Laboisse CL; Mosnier JF
    J Clin Pathol; 2014 Apr; 67(4):307-12. PubMed ID: 24218028
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biomarkers of drugs targeting HER-family signalling in cancer.
    Montemurro F; Scaltriti M
    J Pathol; 2014 Jan; 232(2):219-29. PubMed ID: 24105684
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer].
    Li G; Gu RM; Wen X; Ming XZ; Xia L; Xu XY; Zhang J; Chen HQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):668-72. PubMed ID: 23888453
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors.
    Jácome AA; Wohnrath DR; Scapulatempo Neto C; Carneseca EC; Serrano SV; Viana LS; Nunes JS; Martinez EZ; Santos JS
    Gastric Cancer; 2014 Jan; 17(1):76-86. PubMed ID: 23455716
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.
    Lee J; Kim S; Kim P; Liu X; Lee T; Kim KM; Do IG; Park JO; Park SH; Jang J; Hoe N; Harvie G; Kuller A; Jain A; Meyer G; Leesman G; Park YS; Choi MG; Sohn TS; Bae JM; Lim HY; Singh S; Kang WK
    PLoS One; 2013; 8(1):e54644. PubMed ID: 23372746
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Molecular targeting agents for advanced or recurrent gastric cancer patients].
    Fuse N
    Nihon Rinsho; 2012 Oct; 70(10):1819-26. PubMed ID: 23198568
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multiple synchronous early gastric cancers: high-risk group and proper management.
    Lee IS; Park YS; Kim KC; Kim TH; Kim HS; Choi KD; Lee GH; Yook JH; Oh ST; Kim BS
    Surg Oncol; 2012 Dec; 21(4):269-73. PubMed ID: 22944080
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases.
    Cha MY; Lee KO; Kang SJ; Jung YH; Song JY; Choi KJ; Byun JY; Lee HJ; Lee GS; Park SB; Kim MS
    J Med Chem; 2012 Mar; 55(6):2846-57. PubMed ID: 22372864
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold.
    Ishikawa T; Seto M; Banno H; Kawakita Y; Oorui M; Taniguchi T; Ohta Y; Tamura T; Nakayama A; Miki H; Kamiguchi H; Tanaka T; Habuka N; Sogabe S; Yano J; Aertgeerts K; Kamiyama K
    J Med Chem; 2011 Dec; 54(23):8030-50. PubMed ID: 22003817
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.